Life Sciences Customer Insights
Fully embedded business intelligence with advanced life sciences trained AI, ML, NL
Personalize at Scale
With Omnisight
Give teams a unified and real-time view of their customers so they can offer personalized experiences. Built specifically for life sciences organizations that want to overcome disconnected data silos.
Make Smart Decisions Faster
.png)
Generate Deep Customer Insights
Get business insights that move the needle forward.
Accelerate smart decision making with Business Intelligence (BI) dashboards that are natively integrated into the platform. Avoid lengthy customizations and hit the ground running thanks to comprehensive KPI dictionaries for life sciences organizations.
Gartner Review
(not for circulation)
Gartner Review
(not for circulation)
Gartner Review
(not for circulation)
Gartner Review
(not for circulation)
COVID-19 has placed the life sciences industry around the world under extreme pressure, testing it like no other event. Lockdowns have shocked the system and exposed shortcomings. Every function has had to evaluate and adapt its roles and responsibilities almost overnight. This is all made clear when in April, with Reuters Pharma, we surveyed over 1000 pharma professionals across pharma and biotech – from R&D to commercial – to find out how their functions were adapting and what they saw the future as holding.
This report explores its findings in detail, analyzing them with pharma leaders who are adapting to this new normal and leading their company’s strategies. It looks at the pandemic’s impacts and what this all means for the individual industry functions in the coming months and years.